SCHEMBL18780838

SCHEMBL18780838

CC/C(C)=C1\C(=O)N(C)c2ccccc21

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TTR P02766 3/20 0.53
▸ CES1 P23141 2/20 0.53
▸ RAB9A P51151 2/20 0.50
▸ TRPA1 O75762 1/20 0.50
▸ NPC1 O15118 1/20 0.50
▸ MTOR P42345 1/20 0.50
▸ EPHX2 P34913 2/20 0.49
▸ ALDH1A1 P00352 4/20 0.46
▸ DRD2 P14416 2/20 0.44
▸ HTR6 P50406 2/20 0.44
▸ HPGD P15428 2/20 0.44
▸ KDM4E B2RXH2 1/20 0.44
▸ NR1H2 P55055 2/20 0.43
▸ NR1H3 Q13133 2/20 0.43
▸ MAPT P10636 4/20 0.42
▸ MAPK1 P28482 2/20 0.42
▸ TDP1 Q9NUW8 2/20 0.42
▸ PAX8 Q06710 1/20 0.42
▸ LRRK2 Q5S007 1/20 0.41
▸ LMNA P02545 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28060386 0.84 TTR (0.62) TTRCES1RAB9ATRPA1NPC1
SCHEMBL6325921 0.76 TTR (0.56) TTRCES1RAB9ATRPA1NPC1
SCHEMBL6325919 0.76 TTR (0.56) TTRCES1RAB9ATRPA1NPC1
SCHEMBL16127516 0.73 TTR (0.75) TTRCES1RAB9ATRPA1NPC1
SCHEMBL23449276 0.73 EGFR (0.66) TTRCES1RAB9ATRPA1NPC1
SCHEMBL17169399 0.73 CDC25A (0.49) TTRCES1ALDH1A1NR1H2NR1H3
SCHEMBL2824311 0.72 ALDH1A1 (0.52) TTRCES1RAB9ATRPA1NPC1
SCHEMBL13207350 0.72 ALDH1A1 (0.52) TTRCES1RAB9ATRPA1NPC1
SCHEMBL2824309 0.72 ALDH1A1 (0.52) TTRCES1RAB9ATRPA1NPC1
SCHEMBL2826795 0.72 TTR (0.47) TTRCES1RAB9ATRPA1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170114323-A1 USES OF KINASE INHIBITORS FOR INDUCING AND MAINTAINING PLURIPOTENCY WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH (US) 2017-04-27 — — US disclosed
Send feedback